Dr. Loring is an internationally recognized pioneer in human pluripotent stem cell research in both academia and industry. She is Emeritus Professor and Founding Director of the Center for Regenerative Medicine at Scripps Research in La Jolla. In 2018, she founded Aspen Neuroscience based on her work on developing personalized stem cell-based neuron replacement therapy for Parkinson’s disease. In October 2024, Aspen announced treatment of the first cohort of patients in its Phase 1 clinical trial. Dr. Loring’s scientific publications include landmark studies of the genomics and epigenetics of pluripotent stem cells that have been cited 19,500 times. Dr. Loring serves on two scientific journal editorial boards, on international grant review committees, scientific advisory and ethics boards, and boards of patient advocacy foundations. She is the recipient of the Stem Cell Pioneer award, Rosalind Franklin Society Award, was elected to the American Institute for Medical and Biological Engineering (AIMBE), and was named as one of the Most Influential Women in Advanced Therapies. In addition to human stem cell therapies, she is involved in development of broad applications of pluripotent stem cells, including for rescue of endangered species and for investigating the effects of space flight on the nervous system. Dr. Loring is dedicated to public education and is frequently interviewed by the press, which has called her a “stem cell guru,” “stem cell evangelist,” and the “stem cell godmother”.